Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Abcam

Explore full profile

Life science protein research tools and reagents

Cambridge, United KingdomFounded 1998Biotech & Life Sciences
Valuation $5.70B Market cap · 2026
Revenue $479M Latest reported FY
EBITDA $57M Latest reported FY

At a glance

Status
Listed
Founded
1998
Headquarters
Cambridge, United Kingdom
Listing
IPO 2005
Sector
Biotech & Life Sciences
Power Law
Unicorn$1–10B valuation tierThoroughbred$100M+ revenue

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Investors

1 investor on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later1 investor entered at this stage

  • University of Cambridge

Talent

Book a demo to see the people
Employees mapped 1,878 incl. 13 AI specialists
Founders Hidden — book a demo/100 quality score
Key operators 8 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia 7 alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Alumni founders

5 of 7 startups shown

Former Abcam employees who went on to found companies, sorted by Dealroom signal score.

ChemifyEst. 2019
David CleevelyUnited Kingdom
Signal score96
Parity TechnologiesEst. 2015
Gavin WoodUnited Kingdom
Signal score76
Horizon DiscoveryEst. 2005
Jonathan MilnerUnited Kingdom
Signal score65
QkineEst. 2016
Catherine EltonUnited Kingdom
Signal score65
Storm TherapeuticsEst. 2015
Tony KouzaridesUnited Kingdom
Signal score64
2 more alumni-founded companies in this previewBook a demo

Global footprint

Workforce and web traffic by country
Workforce by country
30 countries with
team presence
🇬🇧 United Kingdom48%
🇺🇸 United States28.4%
🇨🇳 China10%
🇮🇳 India2.7%
🇸🇬 Singapore2.4%
Top 5 of 30 shown
Web traffic by country
670K monthly visits
across markets
🇺🇸 United States28.3%
🇬🇧 United Kingdom8.6%
🏳️ Korea6.6%
🏳️ Republic of4.6%
🇮🇳 India3.1%
Top 5 markets shown

Patents

Estimated portfolio value
$48M

33 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Investments and acquisitions

Disclosed deals where Abcam was the backer or acquirer, 2011–2021. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

8 deals across Abcam's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        Where Abcam deploys vs peers

        Each axis is a Dealroom topic tag — picked from the cluster's most-tagged themes. Values are normalized per axis: the peer with the highest tag-coverage on that axis sits at the edge, others scale relative to them. Toggle between M&A, venture, or both.

        Compare against

        Abcam's portfolio, mapped.

        Stage
        Period
        8 of 8 deals

        Market sentiment

        Posts on X, past 7 days

        An AI-synthesised read of the highest-engagement posts about Abcam on X, ranked by likes and reposts, corporate channels excluded.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See Abcam on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

        Book a demo Explore company profiles